Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-25 @ 2:02 AM
NCT ID:
NCT00002860
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed metastatic melanoma that is deemed grossly surgically resectable
* Multiple resected sites or metastatic melanoma of unknown primary allowed provided all known disease can be grossly resected
* Recurrence in iliac lymph nodes after inguinal lymph dissection allowed
* No metastatic disease beyond the lesions planned for resection
* Confirmed by CT scan of chest, abdomen, pelvis, and CT or MRI of brain within 42 days of study
* Concurrent registration on protocol SWOG-9431 required
PATIENT CHARACTERISTICS:
Age:
* 18 and over
Performance status:
* SWOG 0-2
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* Not specified
Other:
* No other malignancy within the past 5 years except adequately treated basal cell or squamous cell skin cancer, carcinoma in situ of the cervix, or adequately treated stage I or II cancer from which patient is currently disease free
* Not pregnant
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Prior immunotherapy in the adjuvant or metastatic setting allowed
Chemotherapy:
* Prior chemotherapy in the adjuvant or metastatic setting allowed
Endocrine therapy:
* Prior hormonal therapy in the adjuvant or metastatic setting allowed
Radiotherapy:
* Prior radiotherapy in the adjuvant or metastatic setting allowed
Surgery:
* See Disease Characteristics
* At least 14 days since prior surgery in the adjuvant or metastatic setting
Other:
* Recovered from prior therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00002860
Study Brief:
Protocol Section:
NCT00002860